诚达药业：11月19日召开董事会会议

Company Overview - Chengda Pharmaceutical (SZ 301201) announced the convening of its sixth second board meeting on November 19, 2025, to discuss the proposal for the third extraordinary shareholders' meeting of 2025 [1] Financial Performance - For the year 2024, Chengda Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 55.67%, food manufacturing for 43.0%, other businesses for 0.69%, and trading revenue for 0.65% [1] - As of the report date, Chengda Pharmaceutical has a market capitalization of 8.9 billion yuan [1]